Showing results (81-90 of 232) with videos related to
Sort By:
Pageof 24
Cancers|January 23, 2020
Does the Site of Origin of the Microcarcinoma with Respect to the Thyroid Surface Matter? A Multicenter Pathologic and Clinical Study for Risk StratificationGiovanni Tallini, Antonio De Leo, Andrea Repaci, et al.Lancet (London, England)|June 1, 2016
Thyroid cancerMaria E Cabanillas, David G McFadden, Cosimo DuranteClinical Genetics|August 22, 2019
Molecular defects in thyroid dysgenesisCatia Mio, Giorgio Grani, Cosimo Durante, et al.Diabetes Care|July 22, 2016
When Intensive Insulin Therapy (MDI) Fails in Patients With Type 2 Diabetes: Switching to GLP-1 Receptor Agonist Versus Insulin PumpOhad Cohen, Sebastiano Filetti, Javier Castañeda, et al.Oncology Letters|December 30, 2017
Effects of HuR downregulation on anaplastic thyroid cancer cellsLorenzo Allegri, Catia Mio, Diego Russo, et al.Endocrine-Related Cancer|July 13, 2016
RET mutation and increased angiogenesis in medullary thyroid carcinomasAntonella Verrienti, Giovanni Tallini, Chiara Colato, et al.Human Mutation|December 9, 2017
Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancerMarialuisa Sponziello, Silvia Benvenuti, Alessandra Gentile, et al.The Journal of Clinical Endocrinology and Metabolism|July 28, 2010
Identification and optimal postsurgical follow-up of patients with very low-risk papillary thyroid microcarcinomasCosimo Durante, Marco Attard, Massimo Torlontano, et al.Nature Clinical Practice. Endocrinology & Metabolism|February 23, 2007
Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patientsMartin Schlumberger, Ludovic Lacroix, Diego Russo, et al.Thyroid : Official Journal of the American Thyroid Association|July 8, 2015
TERT Promoter Mutations in Papillary Thyroid MicrocarcinomasDario de Biase, Greta Gandolfi, Moira Ragazzi, et al.Pageof 24